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We have characterized a novel animal model of the common inﬂammatory skin disease seborrheic dermatitis (SD)
that involves the expression of the self-specific 2C transgenic T cell receptor on the DBA/2 genetic background.
Opportunistic fungal pathogens are present in the primary histological lesions and severe disease can be mitigated
by the administration of ﬂuconazole, demonstrating a role for infection in disease pathogenesis. Spontaneous
disease convalescence occurs at 70–90 d of age and is preceded by an expansion of CD4þ T cells that partially
restores the T cell lymphopenia that occurs in these animals. The adoptive transfer of syngeneic CD4þ T cells into
pre-diseased DBA/2 2C mice completely abrogates the development of cutaneous disease. The pattern of disease
inheritance in DBA/2 backcrosses suggests that one, or a closely linked group of genes, may control disease
penetrance. Bone marrow reconstitution experiments demonstrated that the DBA/2 susceptibility factor(s) gov-
erning disease penetrance is likely non-hematopoietic since bone marrow from disease-resistant 2C mice can
adoptively transfer the full disease phenotype to non-transgenic DBA/2 animals. This model implicates fungal
organisms and CD4þ T cell lymphopenia in the development of a SD-like condition and, as such, may mimic the
development of SD in acquired immunodeﬁciency syndrome.
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Seborrheic dermatitis (SD) is a common medical condition
afflicting approximately 3% of otherwise healthy individuals
(Bergbrant, 1995; Faergemann, 1998; Ashbee and Evans,
2002; Gupta et al, 2004). The prevalence of this disease is
dramatically higher among immunocompromised patients,
particularly HIV-positive individuals, of whom 40%–80%
have disease (Groisser et al, 1989). The high frequency
among HIV-positive patients with CD4 cell counts between
400 and 500 cells per mm3 has established SD as an early
clinical marker of AIDS (Conant, 1994) and has spurred re-
search into the pathophysiology of this enigmatic disease.
Unna first described SD as a clinical entity more than a
century ago (Bergbrant, 1995). In 1874, Malassez demon-
strated the presence of opportunistic fungi in lesional SD
skin, which were later termed Pityrosporum Malassezii by
Sabouraud (Bergbrant, 1995; Ashbee and Evans, 2002).
This led to the speculation that fungal pathogens played an
active role in disease. Shortly thereafter it was found that
these fungal organisms, the recently taxonomically revised
Malassezia spp. (Gueho et al, 1996), represented normal
inhabitants of the skin and a barrage of studies failed to
conclusively demonstrate that an increased number of them
existed in lesional tissue (Bergbrant, 1995; Ashbee and
Evans, 2002; Gupta and Bluhm, 2004). The introduction of
anti-fungal agents with potent activity against Malassezia,
however, has reawakened interest in the fungal theory of SD
pathophysiology (Gupta and Bluhm, 2004). Treatment stud-
ies have demonstrated that disease remission is associated
with a reduction in the number of these organisms on the
skin, and that recolonization with the fungus leads to a re-
currence of disease (Bergbrant, 1995; Faergemann, 1998;
Ashbee and Evans, 2002; Gupta and Bluhm, 2004). Al-
though these studies seem to have reaffirmed Malassez’s
original hypothesis, several peculiar findings continue to
perplex the understanding of SD pathophysiology. For ex-
ample, the finding that asymptomatic individuals can harbor
enormous numbers of Malassezia on the skin and yet never
develop SD suggests that the number of yeast cells on the
skin is only important for those with an inherent suscepti-
bility to disease (Bergbrant, 1995). The high prevalence of
SD among HIV-seropositive patients (Groisser et al, 1989)
and the association of some SD cases with complement
deficiency (Evans et al, 1977) suggests that various immune
deficiencies can predispose to disease.
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Here we describe a spontaneous murine model of SD-
like disease that has a striking resemblance to human dis-
ease. The disease results from the expression of the 2C T
cell receptor (TCR) transgenes (Sha et al, 1988b) in certain
inbred mouse strains. The 2C TCR recognizes the naturally
processed, ubiquitous p2Ca peptide (LSPFPFDL) present-
ed by the class I molecule Ld (Udaka et al, 1993; Sykulev
et al, 1994). This TCR is positively selected by H-2Kb in H-2b
mice and negatively selected by Ld in H-2d mice (Sha et al,
1988a). On negatively selecting backgrounds, the 2C TCR
recognizes the Ld-p2Ca ligand with high affinity (  2  106
per M) (Sykulev et al, 1994), which results in the compre-
hensive deletion of 2C TCR expressing double positive (DP)
thymocytes (Sha et al, 1988a). This efficient elimination of T
cell progenitor thymocytes precludes the rearrangement of
endogenous TCR chain genes and the generation of a nor-
mal pool of Tcells with diverse TCR specificities (Petrie et al,
1993). The effect of this extensive negative selection is a
severe peripheral lymphopenia of CD4þ and CD8þ T cells.
Although this is of little significance in some strains (Sha
et al, 1988a), DBA/2 2C TCR transgenic mouse (D2C) mice
develop an inflammatory skin disease with a striking re-
semblance to SD. Therefore the D2C mouse may be par-
ticularly well suited to study the pathophysiology of SD that
occurs in the context of AIDS. Specifically, this model may
illustrate how dysregulated systemic immunity interacts
with cutaneous opportunistic pathogens to culminate in SD-
like skin disease.
Results
D2C mice develop a spontaneous inﬂammatory skin
disease D2C animals develop spontaneous cutaneous
changes around the time of sexual maturity (32–38 d),
which occurs within 1–2 wk of weaning (Whittingham and
Wood, 1983), with males tending to develop disease earlier
and more severely than female siblings. The course of dis-
ease is chronic with periodic flares. Disease in D2C mice
occurs in a distinctive distribution involving primarily the
ears, rostrum, and perineum. Although disease is often ex-
tremely inflammatory, only rarely does it extend beyond
these ‘‘seborrheic areas’’ to cause generalized exfoliative
dermatitis. Diseased mice are observed to scratch intensely
at rostral skin, suggesting associated pruritus.
The gross appearance of lesional skin is dependent upon
the chronicity of the lesion. Acute disease invariably begins
in the peri-ocular region with ill-defined erythema and peri-
ocular weeping. No vesicles or pustules are obviously
present; however, occasional inflammatory papules can be
appreciated. This initial blepharitis is later accompanied by
prominent peri-ocular edema that typically results in entro-
pion. At this stage, serous exudate oozes from lesional tis-
sue and yellow-brown crusts form over erythematous skin.
Occasionally, purulent exudate is expressed from the con-
junctiva. Frequently, the lid margins of diseased animals are
sealed by exudate. Although acute skin disease initially has
indistinct margins, the subsequent development of lesional
alopecia sharply marginates disease (Fig 1A).
Ear disease is a prominent feature of acute pathology
and can precede other grossly apparent signs of disease.
Swelling of the pinna in D2C mice is a prominent early fea-
ture of disease (Fig 1B). Ear pathology can become quite
severe, resulting in large concretions of hyperkeratotic
crusted debris occluding the external ear canal (Fig 1C).
Ear disease in these animals typically extends into the ex-
ternal auditory meatus, rather than out from it, and rarely
involves the entire length of the canal.
In more chronic lesions, the prominent swelling and se-
rous crusting of acute disease are replaced by thickening of
the skin and the appearance of fine white scale. This li-
chenified appearance precedes convalescence, the onset
of which is marked by a further reduction of swelling and the
return of the normal dermatoglyphic pattern, and is followed
by the regrowth of hair. Recovery from cutaneous disease
begins at  70 d of age after which only subtle disease, if
any, persists. After the establishment of remission, animals
are resistant to recurrent disease.
To facilitate objective scoring of disease, we have arbi-
trarily divided disease into four stages: stage 0 (S0), no
disease; stage 1 (S1), minimal peri-ocular erythema and
edema; stage 2 (S2), major peri-ocular swelling  lid fusion
with little contiguous spread to surrounding tissue; and
stage 3 (S3), S2 features plus significant spread to contig-
uous tissue (Fig 1A).
Microscopic pathology The microscopic features of dis-
ease are variable and dependent upon the clinical stage of
Figure1
Gross pathology of disease. (A) Gross pathological changes were
arbitrarily divided into four stages: stage 0, no disease; stage 1, minimal
periocular disease; stage 2, major periocular swelling  lid fusion with
little contiguous spread to surrounding tissue; and stage 3, stage 2
features plus significant spread to contiguous tissue. (B) Pre-diseased
21-d-old DBA/2 2C T cell receptor transgenic mice (D2C) and age-
matched DBA/2 controls were assayed for ear thickness. The differ-
ence was found to be statistically significant (po0.05). (C) Ear disease
in a stage 3 D2C mouse is shown. Note the concretion of hyperke-
ratotic debris occluding the external auditory meatus.
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the animal. Lesional tissue obtained from acutely affected
animals possesses: neutrophilic abscesses within the folli-
cles and surrounding epidermis (Fig 2B,C); dilated vessels
within edematous dermal papilla; and scattered areas of
spongiosis involving the follicular infundibulum and epider-
mis adjacent to foci of follicular inflammation (Fig 2C). The
neutrophilic abscesses coalesce into mounds of pyknotic
neutrophilic debris and, together with prominent globules of
eosinophilic serum and compact parakeratotic squames,
form the mound-like scale-crusts that are situated near the
ostia of hair follicles (Fig 2D). Lesions, which clinically have
a lichenified appearance, demonstrate epidermal thickening
from the typical one to two cell layer thickness in normal
murine skin (Fig 2A) to greater than 10 cell layers, and is
sometimes accompanied by finger-like projections of aca-
nthotic epidermis extending into the dermis (Fig 2E). Dense
infiltrates of mixed inflammatory cells that surround glands
and hair follicles are a feature of chronic pathology (Fig 2E–
H). The extent of this pyogranulomatous inflammation is
largely dependent upon the integrity of the adnexal struc-
tures since keratinacious debris released from damaged
follicles is often at the center of inflammatory foci (Fig 2F–H).
Pattern of inheritance and genetics of disease suscep-
tibility To investigate the genetic susceptibility factors that
predispose to disease, we first backcrossed the 2C TCR
transgenes onto various H-2d expressing inbred strains. H-
2d congenic C57BL/6 inbred mouse strain (B6) 2C animals
were found to be resistant to disease, whereas BALB/c 2C
mice developed a mitigated disease phenotype (o50% of
BALB/c 2C mice have clinical disease, n¼10) (Fig 3A). Non-
H-2d expressing backgrounds, such as H-2b expressing B6
and H-2s expressing SJL mice, are resistant to disease (Sha
et al, 1988a).
To further investigate the contribution of the DBA/2 ge-
netic background to disease development, we determined
the frequency and severity of disease development in suc-
cessive backcrosses from the B6 to the DBA/2 background.
Although (B6  DBA/2) N12C (N12C) mice are resistant to
disease (n4100), approximately 50% of N22C (n¼ 50) an-
imals, and 100% of N32C (n¼ 25) and further DBA/2 2C
backcrosses, develop variable degrees of spontaneous cu-
taneous pathology (Fig 3B). There was no difference in the
incidence or severity of disease in H-2b/d and H-2d/d N2
DBA/2 2C backcrosses, indicating that an increased dose
of the cognate 2C transgenic TCR antigen (Ag) is not a
factor in disease pathogenesis (data not shown). The extent
of disease in successive backcrosses to the DBA/2 genetic
background became progressively worse, up to approxi-
mately the fourth backcross generation at which point the
typical D2C pattern of disease penetrance was established
(Fig 3B). This pattern of inheritance is consistent with as few
as one susceptibility factor, or a group of closely linked
genes, controlling disease penetrance. To determine wheth-
er these susceptibility factor(s) were of hematopoietic ori-
gin, we attempted to adoptively transfer disease to H-2d
congenic B6 mice with T cell depleted D2C bone marrow.
Interestingly, none of these recipient mice developed gross
pathological changes or histological stigmata of disease
(Fig 3C). To ensure that the recipient’s hematopoietic sys-
tems were in fact donor derived (B6  DBA/2) N1 mice
(BDN1) were also used as recipients. BDN1 mice normally
express both the ‘‘b’’ and ‘‘d’’ H-2 haplotypes (H-2b/d);
however, after being reconstituted with D2C bone marrow,
lymphocytes from these recipients failed to stain with the
anti-H-2b monoclonal antibody (mAb) HB51, indicating that
their hematopoietic systems were donor derived (data not
shown). These results indicated that the DBA/2 defect(s)
could be non-hematopoietic and that disease might be
transferred to non-transgenic DBA/2 recipients with marrow
from H-2d congenic B6 2C mice. Strikingly, 100% of the
Figure 2
Microscopic pathology of disease. (A) Normally the epidermis (e) of
non-lesional skin consists of one to two cell layers and overlays a non-
inflamed dermis (d), containing plentiful sebaceous glands (g) and hair
follicles (f). (B) The primary histological lesion in acutely diseased mice
is a neutrophilic abscess (na) in the superficial follicle (f). (C) The ne-
utrophilic abscesses are often situated adjacent to spongiotic (s) ep-
idermis and edematous dermal papilla containing dilated blood vessels
(v). (D) The neutrophilic abscesses coalesce into perifollicular mounds
(m) of pyknotic neutrophilic debris. (E) Sub-acute lesions are charac-
terized by primary and secondary histological changes. In these le-
sions, mounds of follicular debris (m) co-exist with acanthotic epidermis
(a) and a multifocal coalescing inflammatory infiltrate (i) that is often
concentrated around damaged follicles (). (F) Chronically lesional skin
is depleted of epidermal adnexa and has moderate acanthosis (a) co-
existing with a dense dermal infiltrate (i). (F, G) Keratinacious debris (k)
released from damaged adnexa is often present in the dermis of
chronic lesions and is surrounded by a dense inflammatory infiltrate (i).
(H) Ear pathology possesses similar histological features with mounds
of debris (m) situated in a follicular distribution.
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DBA/2 recipients of H-2d B6 2C bone marrow developed
the disease phenotype (0% S0, 45% S1, 30% S2, 25% S3,
n¼20), with gross and microscopic features indistinguish-
able from those of D2C mice (Fig 3C).
The striking resemblance between D2C and human SD
pathology (Rook et al, 1992) and the realization that non-
hematopoietic factor(s) may control disease penetrance
suggested that the natural DBA/2 deficiency in the fifth
component of complement (C5) might play a role in disease
pathogenesis (Wetsel et al, 1990). A null mutation of C5 was
previously implicated in an inflammatory form of SD (Evans
et al, 1977) and the mitigated phenotype of C5 sufficient
BALB/c 2C mice provided further support for this hypoth-
esis. To further address this possibility, we used a PCR-
RFLP-based assay on N22C DBA/2 backcrosses to deter-
mine whether the segregation pattern of the deficient DBA/2
C5 allele was similar to the pattern of disease inheritance
(Fig 3D). C5-deficient N22C animals had a slightly worse
phenotype relative to C5-sufficient animals, suggesting that
C5 deficiency may modulate disease expression. However,
several C5 sufficient N42C mice developed severe pathol-
ogy (data not shown), and many N22C mice homozygous for
the defective DBA/2 copy of the C5 gene were completely
asymptomatic (Fig 3D), demonstrating that the defect is
neither necessary nor sufficient for disease.
Identiﬁcation of fungi in the primary histological le-
sion Since the overgrowth of opportunistic basidiomycetes
fungi is a feature of SD pathophysiology (Ashbee and
Evans, 2002), anti-fungal staining of lesional skin was per-
formed to determine whether this was also true for D2C
mice. Grocott’s methenamine silver (GMS) and periodic ac-
id schiff (PAS) staining consistently revealed numerous
small ovoid structures in the superficial layers of keratin and
within the neutrophilic abscesses in lesional tissue. These
were often organized in clusters and possessed pale cen-
ters. No deep invasion or mycelial shift was appreciated in
any of the sections (Fig 4B–F). These positively stained
structures were not readily apparent in non-lesional skin
from diseased animals or from DBA/2 control skin (Fig 4A).
Reversion of cutaneous pathology with anti-fungal
treatment The presence of fungal material in the primary
histological lesion suggested that opportunistic fungal path-
ogens might be playing an active role in disease pathogen-
esis. Imidazole anti-fungal agents have excellent activity in
the skin (Faergemann and Laufen, 1993) and are used to
treat SD (Gupta and Bluhm, 2004). Using an established
dosing strategy for azole-responsive murine fungal infec-
tions (Louie et al, 1998), we found that a considerable
degree of clinical disease in S3 animals was reversed after
a 9-d course of fluconazole whereas the condition of
phosphate-buffered saline (PBS)-treated animals remained
unchanged or deteriorated (Fig 5A,B). Importantly, the clin-
ical resolution of disease was associated with the mitigation
of the typical histological changes and a reduction of PAS
staining in tissue sections taken from previously lesional
skin (Fig 5C).
D2C mice are severely immunocompromised Given that
immunocompromised patients are known to suffer from a
high incidence of SD (Groisser et al, 1989), we investigated
the effect of the strongly self-reactive transgenic 2C TCR on
immune competence. Based upon data from N12C mice
(Sha et al, 1988a), we expected and found that the expres-
sion of the 2C TCR in the H-2d expressing DBA/2 back-
ground induces massive central deletion and a peripheral
lymphopenia (Fig 6A). D2C mice were found to have a 10-
fold reduction in the total number of thymocytes (3.8  106
vs 3.8  107, po0.05) and have 500-fold fewer DP thy-
mocytes (6.1  104 vs 3.2  107, po0.05) compared with
DBA/2 controls. The D2C thymus was also characterized by
a marked reduction of CD8þ and CD4þ single positive cells
relative to non-transgenic controls (Fig 6A). The peripheral
immunophenotype of D2C mice reflects the negatively se-
lecting thymic environment (Fig 6A) with a 4-fold reduction
in total lymphoid CD4þ T cells (7.5  106 vs 2.9  107,
po0.05) accompanying a 13-fold reduction in total lymph-
oid CD8þ T cells (1.4  106 vs 1.8  107, po0.05). We
speculated that this T cell lymphopenia reflected a reduced
thymic output of mature T cells. Supporting this hypothesis,
there were virtually no CD4þ T cells present in the spleens
of 10-d-old D2C mice, whereas spleens from age-matched
DBA/2 animals contained significant numbers of these
cells (3.6  104 vs 4.6  105 cells, respectively, po0.05).
To ascertain whether this level of T cell lymphopenia was
Figure 3
Strain susceptibility and disease modulating factors.
(A) H-2d B6 2C mice are resistant to disease whereas
BALB/c 2C mice develop a mitigated form of disease with
reduced penetrance. (B) Disease incidence and severity
increases with successive backcrosses of the 2C T cell
receptor transgenes from the H-2d congenic B6 back-
ground (B2C) to the DBA/2 background (DBA/2 2C T cell
receptor transgenic mice (D2C)). (C) Bone marrow from
D2C and B6 H-2d 2C animals was adoptively transferred to
lethally irradiated non-transgenic B6 H-2d and DBA/2 re-
cipients, respectively. Photographs of the chimeric mice
are shown along with representative histology from the
rostral skin. (D) DNA from C5-sufficient, C5-deficient, and
an animal heterozygous for these C5 alleles was amplified
and digested with HindIII demonstrating how the C5 gen-
otype can be determined using this technique. This assay
was used to determine the C5 genotypes of N22C back-
crosses to the DBA/2 background, which were compared
with the extent of clinical disease.
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associated with functional immunocompromise, the T cell-
dependent Ag hen egg lysozyme (HEL) was used to immu-
nize D2C mice and syngeneic DBA/2 littermates. Ten days
after challenge, DBA/2 mice had mounted a strong humoral
response but D2C mice had not (Fig 6B). Interestingly, de-
spite a failure in Ag-specific antibody generation, D2C mice
possess massively increased levels of serum IgG (Fig 6C)
and enlarged lymphoid organs (Fig 6D) that contain normal
to increased numbers of B lymphocytes (Delaney, 1999).
Correction of CD4þ T cell lymphopenia correlates with
disease remission and occurs as a result of massive
Ag-driven peripheral expansion To first investigate the
possible link between T cell lymphopenia and disease, we
examined the peripheral blood CD4 counts immediately be-
fore the time of pubescence (Whittingham and Wood, 1983),
when animals become susceptible to disease. The CD4
counts in these mice were nearly 30-fold lower than control
counts (Fig 6E). Since CD4þ T cells increase over time in
D2C mice, we speculated that disease convalescence might
occur as a result of the acquisition of a protective number of
CD4þ T cells. Examination of convalescent D2C mice re-
vealed that the CD4þ Tcells in these animals had expanded
over 400% since pubescence whereas the CD4þ T cells
from DBA/2 control animals had expanded a meager 28%
over this same window of disease susceptibility (Fig 6E).
Complete disease remission occurs when CD4þ Tcells have
accumulated to between 400 and 1000 cells per mm3, which
takes place several weeks after the onset of convalescence.
To better demonstrate the extent of CD4þ T cell periph-
eral expansion in D2C mice, we administered a 10-d course
of bromodeoxyuridine (BrdU) to 50-d-old D2C mice and
age-matched DBA/2 controls. Consistent with previous
studies (Tough et al, 1999), we found that this short admin-
istration of BrdU labels negligible numbers of peripheral
CD4þ Tcells from non-transgenic mice whereas 30% of the
CD4þ T cells from D2C mice incorporated the marker, in-
dicating that massive peripheral T cell expansion was oc-
curring (Fig 6F). To determine whether this represented
homeostatic expansion to fill a lymphopenic environment or
whether these cells were dividing after exposure to cognate
Ag, we stained these cells with the memory markers CD44
and CD62L as well as the acute activation marker CD69.
The vast majority of CD4þ T cells from DBA/2 mice ex-
pressed an immunophenotype typical of naive cells (CD44lo,
CD69, and CD62Lhi), whereas the majority of CD4þ Tcells
from D2C mice were CD44hi, CD69þ , and CD62Llo (Fig 6F).
This pattern suggests that the expansion of CD4þ T cells in
D2C mice is Ag driven (Goldrath et al, 2000).
The adoptive transfer of syngeneic CD4þ T cells abro-
gates the development of disease To see whether disease
Figure5
Treatment of diseased DBA/2 2C T cell receptor transgenic mice
(D2C) with anti-fungal medication. (A) Acutely ill D2C mice with se-
vere pathological changes were treated for 9 d with phosphate-buff-
ered saline (PBS) or fluconazole. (B) Recovery of mice was monitored
over the 9-d treatment period. Mice were considered to be disease free
when hair regrowth began over lesional rostral skin. (C) Representative
histological sections stained with hematoxylin & eosin (H&E) and pe-
riodic acid schiff (PAS) are shown. Note the punctate epidermal PAS
staining () in the PBS control skin, which underlies a large mound of
debris (m) that also stains prominently with PAS because of the inclu-
sion of serum.
Figure 4
Anti-fungal staining of lesional skin. (A) Non-lesional epidermis (e)
does not stain with Grocott’s methenamine silver (GMS); however, GMS
stains dermal connective tissue (c). (B) Finely speckled staining with
GMS is frequently observed in lesional epidermis and often surrounding
follicular abscesses (na). (C, D) High-powered views of lesional skin
demonstrate small round GMS-stained structures () in the epidermis
below hyperkeratotic (hk) mounds and within the neutrophilic abscess-
es (na). (E, F) Small structures () clustered together around keratin-
ocytes (k) from lesional skin stain with periodic acid schiff (PAS) as well.
Note the PAS-positive globules of serum (g) within the neutrophilic ab-
scess (na) and nascent scale-crusts.
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remission in D2C mice is induced by the acquisition of suf-
ficient numbers of CD4þ T cells, we sought to abrogate the
development of pathology in pre-diseased D2C mice by the
adoptive transfer of syngeneic DBA/2 CD4þ T cells. These
recipient mice were completely resistant to the develop-
ment of disease (100% S0, n¼12) whereas D2C recipients
of PBS developed typical pathological changes (Fig 7A,B).
Sections taken from the skin of these CD4þ cells recipients
were devoid of any microscopic stigmata of disease and
were indistinguishable from DBA/2 skin sections (Fig 7C).
This transfer reconstituted D2C recipients with a functional
humoral immune system (Fig 7D), and also resulted in the
amelioration of other phenotypic abnormalities such as
the development of lymphadenopathy and splenomegaly
(Fig 7E). The hypergammaglobulinemia typical of D2C mice,
however, was only partially corrected by the adoptive trans-
fer of CD4þ T cells (Fig 7F). Although this reduction was
found to be statistically significant (po0.05), the concen-
tration of serum IgG in recipients of CD4þ T cells was still
nearly 10-fold higher than in age-matched DBA/2 controls.
Discussion
Herein we have described a novel spontaneous animal
model of SD-like disease, which arises in 2C TCR express-
ing DBA/2 mice (D2C mice) housed under specific patho-
gen-free conditions. Histological sections of diseased skin
from D2C mice consistently demonstrated the presence of
small round fungal structures in diseased epidermis. These
structures were not apparent in non-lesional skin from D2C
mice or control DBA/2 skin. The direct visualization of fungal
overgrowth in conventionally processed histological sec-
tions, without usage of the specialized techniques normally
utilized to demonstrate fungal overgrowth in SD (Bergbrant,
1995), suggested that this was a significant aspect of the
model. Moreover, treatment with the anti-fungal drug flu-
conazole reduced the extent of PAS staining in previously
lesional skin and hastened clinical recovery. Fungal over-
growth and skin lesions in D2C mice occur in areas known
to have high concentrations of sebaceous glands (Gude
et al, 1982). Moreover, D2C disease has a slight male
Figure7
CD4þ T cell adoptive transfer. (A) Twenty-one day old pre-diseased
DBA/2 2C T cell receptor transgenic mice (D2C) received phosphate-
buffered saline (PBS) or 2  107 syngeneic DBA/2 CD4þ T cells. Rep-
resentative photographs are shown. (B) The effectiveness of the cell
transfer was quantified by classifying resulting disease according to
stage. (C) Representative hematoxylin & eosin-stained histological
sections from the CD4þ T cell and PBS groups are shown. (D) Four
weeks after transfer, the recipients and DBA/2 control animals were
immunized with hen egg lysozyme (HEL) and assayed for HEL-specific
IgG (the difference between the anti-HEL response of DBA/2 mice and
D2C recipients of CD4þ T cells was not statistically significant). (E)
Representative lymphoid organs from D2C recipients of PBS and
syngeneic CD4þ T cells are shown. (F) Total serum IgG is shown for
DBA/2 mice, as well as for D2C recipients of either syngeneic CD4þ T
cells or PBS (the serum IgG concentration in D2C recipients of CD4þ T
cells was found to differ significantly from this same measure in both
DBA/2 mice and D2C recipients of PBS (po0.05)).
Figure 6
Immunological defects of DBA/2 2C T cell receptor transgenic
mice (D2C). (A) Thymocytes and lymph node (LN). cells from DBA/2
and D2C mice were stained with monoclonal antibodies directed
against CD4 and CD8. Dot plots are gated on live cells. (B) Forty days
old DBA/2 and D2C mice were immunized with hen egg lysozyme (HEL)
and assayed for HEL-specific IgG by ELISA. (C) Total serum IgG was
determined in DBA/2 and diseased D2C mice by ELISA. (D) Repre-
sentative photographs are shown of lymphoid organs from DBA/2 and
diseased D2C mice. (E) Peripheral blood CD4 counts were determined
for 20-d-old pre-diseased D2C mice, 75-d-old convalescent D2C mice,
and age-matched DBA/2 controls. (F) LN cells from 50-d-old D2C and
DBA/2 mice were stained with the indicated markers. Histograms are
gated on live CD4þ T cells. For bromodeoxyuridine (BrdU) staining,
animals were first fed BrdU for 10 d.
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predominance and does not occur before puberty, sug-
gesting that an influence of androgens on the piloseba-
ceous unit may play a significant role in pathogenesis.
These findings are consistent with the distribution, sex
predilection, and timing of disease in human SD (Rook
et al, 1992; Faergemann, 1998) and the premise that dis-
ease in D2C mice is initiated by lipophilic fungi. The iden-
tification of the pathogenic organisms in this condition,
however, has been complicated by the fact that culturing
lipid-dependent fungi is notoriously difficult. Previous
studies have indicated that Malassezia spp. cannot be cul-
tured from rodent integument (Guillot et al, 1994); however,
further studies will determine whether an unusual suscep-
tibility to these organisms allows the skin of D2C mice to be
colonized.
It is likely that trauma may also affect the pattern as well
as the ultimate phenotype of disease since we have ob-
served that diseased D2C mice scratch rostral skin more
frequently than non-transgenic controls (data not shown).
The frequent occurrence of ruptured follicles and spillage of
keratinaceous debris in histological sections suggest that
trauma participates in lesion induction. The intense scratch-
ing of diseased tissue by D2C mice may account for the
lichenification noted in chronic lesions as well.
The results of this study suggest that an impairment of
adaptive immunity, namely a deficiency of CD4þ T cells in
D2C mice, is necessary for disease. This CD4þ Tcell lymph-
openia is induced by the comprehensive negative selection
of 2C TCRþ DP thymocytes. In non-H-2d expressing back-
grounds where this extensive central deletion does not occur,
2C mice are resistant to disease (Sha et al, 1988a), attesting
to the requirement of a self-reactive TCR in disease patho-
physiology. CD4þ Tcell lymphopenia is, however, clearly not
sufficient for disease since H-2d congenic B6 2C and N12C
mice possess a similar level of CD4þ T cell lymphopenia yet
remain resistant to disease. Familial clustering of human SD
is known to occur, suggesting that genetic alterations may
predispose to disease; however, the pattern of inheritance of
this condition has not yet been determined (Braun-Falco
et al, 1991). It is clear from the results of this study that DBA/
2 genetic susceptibility factor(s) are important for D2C dis-
ease and our backcross and bone marrow transfer experi-
ments suggest that as few as one non-hematopoietic DBA/2
defect may control disease penetrance.
Given the role of opportunistic fungi, we reasoned that
the susceptibility factor(s) controlling disease penetrance
most likely compromise resistance to infection. A mutation
in the DBA/2 C5 gene had previously been found to pre-
dispose to fungal infection and has been the basis for using
these animals as a model organism for in vivo fungal studies
(Hector et al, 1990). Although the DBA/2 C5 defect was not
found to be critical for disease pathogenesis in D2C mice, it
did modulate disease severity. The possibility that multiple
genetic defects and environmental insults contribute to dis-
ease pathophysiology suggests that a more complex mode
of inheritance may be at work in the model.
Although the aforementioned data support a role for
immunodeficiency and opportunistic pathogens in the mod-
el, immune dysregulation may also be of paramount impor-
tance. The finding that sentinel BALB/c nude mice (T, B, and
NK lymphocyte deficient) remained disease resistant (data
not shown) when co-housed with affected D2C mice sug-
gests that immunopathology participates in generating the
cutaneous phenotype. BALB/c nude mice share the genetic
background that predisposes BALB/c 2C mice to disease,
but lack the population of vigourously expanding CD4þ T
cells as well as the potential to generate autoreactive 2C
TCRþ T cells. 2C mice on negatively selecting genetic
backgrounds possess peripheral T lymphocytes expressing
high levels of the clonotypic 2C TCR (Sha et al, 1988a).
Although such cells appear to be anergized (Sha et al,
1988a; Caveno et al, 1999), it is possible that these cells
may exacerbate immunopathology, and thereby contribute
to the ultimate phenotype of disease.
The association between disease and CD4þ T cell
lymphopenia in D2C mice closely parallels that which oc-
curs in AIDS-related SD. When D2C mice become suscep-
tible to disease at approximately 28 d of age, their CD4
counts of 66  35 cells per mm3 are nearly 10-fold lower
than the 400–500 cells per mm3 threshold at which HIV-
positive patients begin to develop SD (Conant, 1994). The
finding that disease convalescence in these animals occurs
around the time that this critical threshold is acquired and
that the restoration of the CD4þ T cell compartment in D2C
mice suppresses cutaneous pathology provides further
support for this parallel. Furthermore, D2C mice possess
a number of additional phenotypes that are hallmarks of
AIDS, such as lymphoid organomegaly and intermittent di-
arrhea (Delaney, 1999), as well as the coexistence of hype-
rgammaglobulinemia and humoral immune dysfunction
(Pahwa, 1989; Johanson, 1996; Mindel and Tenant-Flow-
ers, 2001). The finding that these mice could not mount a
specific response against HEL suggested that their gam-
mopathy resulted from the dysregulation of B cells rather
than from a greater exposure to environmental Ag because
of associated skin inflammation and barrier disruption. In-
terestingly, the hypergammaglobulinemia that occurs in
D2C mice was mitigated, but not completely abrogated, by
the adoptive transfer of CD4þ T cells. The complete abro-
gation of this B lymphocyte defect, however, may have ne-
cessitated an earlier transfer of CD4 T cells because this
hematological alteration likely begins at an early age. The
cutaneous disease in these animals may be particularly well
suited to study the pathophysiology of SD that occurs dur-
ing the course of HIV infection. However, D2C cutaneous
disease overlaps somewhat with a number of additional
conditions such as Malassezia folliculitis, atopic dermatitis,
and the veterinary conditions Malassezia otitis and derma-
titis; thus, the model could have implications for a number
of additional clinical entities. The elevation of IgE seen in
D2C mice is particularly intriguing (Delaney, 1999), indicat-
ing a possible overlap with atopic dermatitis of the head
and neck region, a condition previously associated with
Malassezia fungi (Ashbee and Evans, 2002).
In summary, the D2C mouse develops skin disease that
has morphological and pathological similarities to SD. It is
likely that a combination of factors confers to these mice a
unique susceptibility to develop spontaneous psoriasiform
skin disease when housed under specific pathogen-free
conditions. We propose that the D2C mouse may serve as a
veritable model for SD-like disease, particularly disease that
occurs in AIDS, and its timely development will elucidate
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the interplay between infection and immunity in this poorly
understood disease.
Materials and Methods
Mice Breeders for 2C TCR transgenic mice (Sha et al, 1988b) were
kindly provided by Dr Denis Loh (then at Howard Hughes Medical
Institute, Washington University, St Louis, Missouri). 2C TCR
transgenic mice were bred from an H-2b expressing C57BL/6
(B6) background onto the H-2d expressing BALB/c, DBA/2, and B6
(B6.C-H-2d/bBy) backgrounds. N22C, N32C, N42C, and subse-
quent backcrosses to the DBA/2 background were analyzed for
the development of disease (at least 15 animals were scored for
each backcross generation). 2C mice were genotyped by PCR on
ear punch DNA using primers specific for the Vb 8.2 (50-AGA TAT
CCC TGA TGG ATA CAA GGC-30), and Jb 2.5 (50-CTA ACA CGA
GGA GCC GAG TGC CTG-30) TCR chains (Nucleic Acid-Protein
Service Unit, University of British Columbia). A 250 bp band is
amplified from 2C TCR-positive animals whereas amplification of
non-transgenic control DNA results in a faint smear. UBC’s Com-
mittee on Animal Care approved the animal studies described.
Ear thickness determination The pinna of 21-d-old, pre-dis-
eased D2C and age-matched DBA/2 mice (n¼ 6 animals per
group) were measured using a Mitutoyo pocket thickness gage
(Long Island Indicator Service, New York, NY, USA).
Histology Tissue was fixed as previously described (Oble and
Teh, 2001) and sections were stained with hematoxylin & eosin
(H&E), GMS, or PAS stains.
Adoptive transfer of bone marrow Bone marrow cells were de-
pleted of mature T cells using the anti-Thy-1.2 mAb (J1j.10, Amer-
ican-type culture collection (ATCC), Manassas, Virginia) and Low-
Tox-M rabbit complement (Cedarlane, Ontario, Canada) according
to company specifications. 1  107 cells were injected by tail vein
into irradiated (1150 cGy) recipients (n¼ 20 animals per recipient
group).
Genotyping alleles of the C5 A 328–330 bp fragment of the C5
gene, containing the 2 bp deletion known to induce C5 deficiency
(Wetsel et al, 1990), was amplified using the following primers: 50-
CCA TCT GTC TCC AGA TGA ATA TGT-30 and 50-ATA ATG GGA
GTC ATC TGC GTT T-30 (Nucleic Acid-Protein Service Unit, Uni-
versity of British Columbia). This mutation, occurring in C5-
deficient strains, disrupts a HindIII restriction site and, as such,
digestion of the resulting amplicons with HindIII (Life Technologies,
Burlington, Canada) was used to genotype the animals. C5 suf-
ficient strains have a 211 and 119 bp band whereas deficient an-
imals have a single 328 bp band. Animals heterozygous for the C5
alleles possess all three bands.
Fluconazole administration Fifty days old severely diseased
D2C mice were treated once daily for 9 d with i.p. injections of
fluconazole (12 mg per kg, Pfizer, Quebec, Canada) or PBS (n¼ 4
animals per group). Animals were considered to be convalescing at
the first observation of new hair growth on rostral skin.
Flow cytometry mAb used for FACS are as follows: HB51 (H-2
KbDb, ATCC); 53.67 (CD8a, BD PharMingen, San Diego, California);
GK1.5 (CD4, BD PharMingen); H1.2F3 (CD69, Cedarlane); IM7.8.1
(CD44, Cedarlane); MEL-14 (CD62L, BD PharMingen); 145.2C11
(CD3, BD PharMingen); and B44 (BrdU, BD PharMingen).
HEL immunization and HEL ELISA HEL (Sigma, St Louis, Mis-
souri) was diluted in PBS and emulsified with an equal volume of
TiterMax (Sigma). 0.1 mL of the emulsified Ag (50 mg HEL) was
administered i.p. After 10 d, serum was collected. Immulon plates
(Dynatech Laboratories, Indianapolis, Indiana) were coated with
100 mL of HEL at a concentration of 0.5 mg per mL in 50 mM
carbonate buffer (pH 9.6). Plates were then blocked with 2% BSA
in PBS after which serum was diluted in blocking solution and
incubated. Alkaline phosphatase-conjugated goat anti-mouse IgG
anti-sera was used for detection (1030–04, Southern Biotech-
nology, Birmingham, Alabama). Plates were read at 405 nm on
a Spectra Max 250 plate reader (Molecular Devices, Sunnyvale,
California).
Serum IgG ELISA Immulon plates were coated with 100 mL of
goat F(Ab0)2 anti-mouse Ig (1012–01, Southern Biotechnology) at a
concentration of 4 mg per mL in carbonate buffer. Blocking, sample
incubations, and detection of bound IgG were performed as de-
scribed for the HEL ELISA. The Thy1.1-specific murine IgG2a mAb
HIS51 (eBioscience, San Diego, California) was used to develop a
standard curve.
CD4 counts An aliquot of heparinized tail vein blood was diluted in
0.83% NH4Cl RBC lysis buffer after which the total WBC counts
were determined using a hemocytometer. The remaining blood
was centrifuged over histopaque (Sigma) for the collection of in-
terface cells. Staining with GK1.5, and 145.2C11 was used to
identify the percentage of these that were CD4þ T cells.
BrdU incorporation in vivo Mice were fed BrdU (Sigma) in their
drinking water (0.8 mg per mL) for 10 d before being sacrificed and
assayed for BrdU incorporation as previously described (Tough
et al, 1999).
Adoptive transfer of puriﬁed CD4þ T cells Purified CD4þ Tcells
were obtained by incubating lymph node (LN) cells with biotiny-
lated GK1.5 (BD PharMingen) and subsequently with streptavidin-
conjugated magnetic microbeads (Miltenyi Biotec, Auburn, Cali-
fornia) before being applied to a Macs Separation Column (Miltenyi
Biotec). This procedure yields 495% purity of CD4þ T cells.
2  107 purified CD4þ T cells in 0.5 mL PBS were administered by
tail vein to 20-d-old pre-diseased D2C recipients. Control animals
received an i.v. injection of PBS (n¼ 12 animals per group).
Statistics Student’s two-tailed t tests were used for the statistical
analysis of data.
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